Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06482957 · ClinicalTrials.gov registry record

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

A clinical trial of Sarcoma, sponsored by Vanderbilt-Ingram Cancer Center.

Recruiting
Registry status
2,100
Enrollment target
1
Study location

NCT06482957 is a study of Sarcoma that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 2,100 participants, above the 904-participant average among 122 other Sarcoma trials with a reported enrollment target (132% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06482957, a study of Sarcoma, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.

RECRUITING
Registry status
2,100 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Conditions Studied

Sarcoma

Interventions

  • OTHER Urine Collection
  • OTHER Blood Collection
  • OTHER Surveys
  • OTHER Saliva Collection
  • OTHER Stool Collection

Study Locations (1)

Tennessee

  • Vanderbilt University/Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 2,100 participants
Start Date 2022-04-01
Est. Completion 2029-04

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06482957

The ClinicalTrials.gov registry entry for NCT06482957 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 904-participant average among 122 other Sarcoma trials with a reported enrollment target (132% higher). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 5 interventions - of which Urine Collection is the first listed.

NCT06482957 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06482957 about?

NCT06482957 is a clinical study titled "Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan". This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

What is the current status of trial NCT06482957?

This trial is currently recruiting. The enrollment target is 2,100 participants. The study started on 2022-04-01. Estimated completion is 2029-04.

What conditions does trial NCT06482957 study?

This clinical trial studies the following conditions: Sarcoma.

What interventions are being tested in trial NCT06482957?

The interventions under investigation include: Urine Collection (OTHER), Blood Collection (OTHER), Surveys (OTHER), Saliva Collection (OTHER), Stool Collection (OTHER).

Who is sponsoring clinical trial NCT06482957?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06482957 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sarcoma

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.